ITMI960378A0 - - Google Patents

Info

Publication number
ITMI960378A0
ITMI960378A0 ITMI960378A ITMI960378A ITMI960378A0 IT MI960378 A0 ITMI960378 A0 IT MI960378A0 IT MI960378 A ITMI960378 A IT MI960378A IT MI960378 A ITMI960378 A IT MI960378A IT MI960378 A0 ITMI960378 A0 IT MI960378A0
Authority
IT
Italy
Application number
ITMI960378A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI960378(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to IT96MI000378A priority Critical patent/IT1282705B1/it
Publication of ITMI960378A0 publication Critical patent/ITMI960378A0/it
Priority to ES97906125T priority patent/ES2213205T3/es
Priority to DK97906125T priority patent/DK0906100T3/da
Priority to AU20932/97A priority patent/AU2093297A/en
Priority to JP53057997A priority patent/JP2001511763A/ja
Priority to PT97906125T priority patent/PT906100E/pt
Priority to PCT/EP1997/000897 priority patent/WO1997031637A1/en
Priority to EP97906125A priority patent/EP0906100B1/en
Priority to DE69727378T priority patent/DE69727378T2/de
Priority to AT97906125T priority patent/ATE258438T1/de
Priority to US08/807,338 priority patent/US5990114A/en
Publication of ITMI960378A1 publication Critical patent/ITMI960378A1/it
Publication of IT1282705B1 publication Critical patent/IT1282705B1/it
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Spinning Or Twisting Of Yarns (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
IT96MI000378A 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria IT1282705B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT96MI000378A IT1282705B1 (it) 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
AT97906125T ATE258438T1 (de) 1996-02-28 1997-02-25 Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz
PT97906125T PT906100E (pt) 1996-02-28 1997-02-25 Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria
DK97906125T DK0906100T3 (da) 1996-02-28 1997-02-25 Anvendelse af 5-HT1A-receptorantagonister til behandling af urininkontinens
AU20932/97A AU2093297A (en) 1996-02-28 1997-02-25 Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence
JP53057997A JP2001511763A (ja) 1996-02-28 1997-02-25 尿失禁の治療のための５−ｈｔ▲下１ａ▼受容体アンタゴニストの使用
ES97906125T ES2213205T3 (es) 1996-02-28 1997-02-25 Uso de antagonistas del receptor 5-ht1a para el tratamiento de la incontinencia de orina.
PCT/EP1997/000897 WO1997031637A1 (en) 1996-02-28 1997-02-25 Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence
EP97906125A EP0906100B1 (en) 1996-02-28 1997-02-25 Use of 5-ht 1a? receptor antagonists for the treatment of urinary incontinence
DE69727378T DE69727378T2 (de) 1996-02-28 1997-02-25 Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz
US08/807,338 US5990114A (en) 1996-02-28 1997-02-28 Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000378A IT1282705B1 (it) 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria

Publications (3)

Publication Number Publication Date
ITMI960378A0 true ITMI960378A0 (en:Method) 1996-02-28
ITMI960378A1 ITMI960378A1 (it) 1997-08-28
IT1282705B1 IT1282705B1 (it) 1998-03-31

Family

ID=11373430

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI000378A IT1282705B1 (it) 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria

Country Status (10)

Country Link
EP (1) EP0906100B1 (en:Method)
JP (1) JP2001511763A (en:Method)
AT (1) ATE258438T1 (en:Method)
AU (1) AU2093297A (en:Method)
DE (1) DE69727378T2 (en:Method)
DK (1) DK0906100T3 (en:Method)
ES (1) ES2213205T3 (en:Method)
IT (1) IT1282705B1 (en:Method)
PT (1) PT906100E (en:Method)
WO (1) WO1997031637A1 (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
SE510305C2 (sv) 1997-05-30 1999-05-10 Astra Ab Nytt salt
AU8130298A (en) * 1997-07-15 1999-02-10 Sankyo Company Limited Piperazine derivatives
US6906069B1 (en) 1999-01-08 2005-06-14 Amgen Inc. LXR modulators
WO2001060818A1 (en) * 2000-02-14 2001-08-23 Tularik Inc. Lxr modulators
US6673543B2 (en) 2000-04-05 2004-01-06 Tularik, Inc. Solid phase synthesis of LXR ligands
DK1392676T3 (da) * 2001-02-16 2007-04-10 Aventis Pharma Inc Hidtil ukendte heterocykliske urinstofderivater og deres anvendelse som dopamin -D3 - receptorligander
IL160852A0 (en) * 2001-09-27 2004-08-31 Pharmacia Ab Pharmaceutical compositions for the treatment of urinary disorders
WO2003063796A2 (en) 2002-01-30 2003-08-07 Tularik Inc. Heterocyclic arylsulfonamidobenzylic compounds
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
JPWO2006082872A1 (ja) * 2005-02-04 2008-06-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 １−（ピペリジン−４−イル）−１ｈ−インドール誘導体
JP4932717B2 (ja) 2005-05-11 2012-05-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピペリジン環を有するインドール誘導体の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
SG65570A1 (en) * 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
GB9417135D0 (en) * 1994-08-23 1994-10-12 Medinnova S F Method

Also Published As

Publication number Publication date
ITMI960378A1 (it) 1997-08-28
ATE258438T1 (de) 2004-02-15
EP0906100B1 (en) 2004-01-28
WO1997031637A1 (en) 1997-09-04
AU2093297A (en) 1997-09-16
PT906100E (pt) 2004-06-30
DE69727378T2 (de) 2004-12-09
EP0906100A1 (en) 1999-04-07
DK0906100T3 (da) 2004-05-03
IT1282705B1 (it) 1998-03-31
DE69727378D1 (de) 2004-03-04
JP2001511763A (ja) 2001-08-14
ES2213205T3 (es) 2004-08-16

Similar Documents

Publication Publication Date Title
AR026660A2 (en:Method)
BRPI9713914B8 (en:Method)
ITMI960046A0 (en:Method)
ITMI960553A0 (en:Method)
BR7600721U (en:Method)
BR7601346U (en:Method)
BR9603859A (en:Method)
CN3039060S (en:Method)
CN3039213S (en:Method)
CN3040024S (en:Method)
CN3040367S (en:Method)
CN3040543S (en:Method)
CN3040805S (en:Method)
CN3041207S (en:Method)
CN3041374S (en:Method)
CN3041383S (en:Method)
CN3042193S (en:Method)
CN3042289S (en:Method)
CN3042589S (en:Method)
CN3043305S (en:Method)
CN3044168S (en:Method)
CN3044346S (en:Method)
CN3044347S (en:Method)
CN3044348S (en:Method)
CN3044349S (en:Method)

Legal Events

Date Code Title Description
0001 Granted